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332Objective: The objective of our study was to report on the total experience in thoracic aortic surgery over
a 40-year time period for a single institution.
Methods:All 1075 patients who underwent surgery for thoracic aortic pathology from 1972 to 2011 (n¼ 1159)
were included. Patient, procedural, and follow-up information was obtained from hospital records and the civil
registry. Patients were grouped into 4 categories: acute type A dissection (n ¼ 261), other ascending aortic/arch
surgery (n¼ 626), descending aortic surgery (n¼ 175), and thoracoabdominal surgery (n¼ 97). Risk factors for
early and late mortality and the incidence of reoperations were analyzed.
Results: The annual number of operations increased significantly over time. In all 4 patient groups, early mor-
tality (in hospital or within 30 days of operation) decreased significantly over time to 15.3% in group 1, 1.9% in
group 2, 0% in group 3, and 10.5% in group 4 during the contemporary time period 2007 to 2011. Overall
actuarial survival was 54.3% (95% confidence interval, 50.7-57.9) after 10 years and 27.8% (95% confidence
interval, 26.4-38.3) after 20 years. Late survival improved over time, but was reduced compared with the general
population and was related predominantly to preexisting risk factors. In 80 patients, 111 reoperations were nec-
essary, most frequently in group 1 patients and in patients with connective tissue disease.
Conclusions: Thoracic aortic operations were performed increasingly during a 40-year time period. Early mor-
tality decreased and late survival increased significantly in all patient groups. A significant proportion of patients
required multiple operations. (J Thorac Cardiovasc Surg 2014;147:332-43)Thoracic aortic aneurysm is a frequently encountered condi-
tion, potentially leading to lethal complications or serious
morbidity.1-3 The exact prevalence of thoracic aortic
aneurysms is not known. In the United States, aortic
aneurysms were ranked 19 in the 2007 mortality statistics,
with 13,000 deaths (0.5% of all deaths).4 When dissection
or rupture occurs as complication of a thoracic aneurysm,
emergency surgical treatment is most often the only avail-
able option to save a patient’s life. Because these emergency
operations have considerable operative mortality and com-
plication rates, and because patients might be confronted
with potential long-term consequences, elective surgery
even in asymptomatic patients with aortic dilatation is rec-
ommended in recent guidelines.5 The aortic dimension war-
ranting operation depends on the underlying diagnosis.
In this setting, surgery of the thoracic aorta has evolved
from a small, but high-impact part in terms of mortality
and morbidity of the total cardiothoracic surgical workloade Departments of Cardio-Thoracic Surgery,a Anesthesiology,b and Cardio-
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In this study, we report our total experience with thoracic
aortic surgery since 1972, specifically early patient outcome
as well as long-term results in 4 major subgroups. Further-
more, we analyze evolution over time in timing and charac-
teristics of operations and operative results.METHODS
From our institutional aortic surgery database, we extracted 1159 con-
secutive thoracic aortic procedures in 1075 patients between 1972 and
2011. We excluded patients with primary aortic coarctation and patients
who underwent aortic root replacement for pure aortic valve pathology (en-
docarditis, aortic allograft root replacement, or pulmonary autograft
replacement for isolated valve pathology) or complex congenital pathol-
ogy. Patients who underwent thoracic stent–graft procedures were
excluded. Patients were categorized into 4 groups: group 1, acute type A
dissections; group 2, ascending aortic and/or arch procedures, excluding
acute type A dissections; group 3, descending aortic procedures; and group
4, thoracoabdominal procedures. Institutional review board approval was
obtained for this retrospective follow-up study (Medical Ethics Committee
no. 2011-064); the institutional review board waived informed consent.
The indications for operation are displayed in Table 1. Preoperative patient
characteristics are displayed in Table 2. Operations within 24 hours of onset
of complaints are classified as acute, operations within 14 days or during
the initial hospital admission are classified as urgent. The other operations
were elective.
Operation
Over time, the operations were performed by 17 attending staff
surgeons. Over the years, anesthetic and extracorporeal circulation
management and preferred surgical procedures evolved.ery c January 2014
Abbreviations and Acronyms
CI ¼ confidence interval
HR ¼ hazard ratio
OR ¼ odds ratio
SD ¼ standard deviation
TEVAR ¼ thoracic endovascular aortic
replacement
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median sternotomy using cardiopulmonary bypass. Routine arterial cannu-
lation was in the ascending aorta. Alternative arterial cannulation sites
(femoral artery or subclavian artery) were used for acute aortic dissections
or when otherwise indicated. Venous cannulation was routinely in the right
atrium. Deep hypothermia and circulatory arrest were used when indicated.
Additional retrograde or antegrade cerebral perfusion was introduced in
1997 and was used in selected cases. In patients who required multiple
periods of cardiopulmonary bypass, aortic crossclamping, or circulatory
arrest, the total times were calculated by adding these periods. Cold crys-
talloid cardioplegia was used for cardiac protection. For aortic replace-
ment, we used various types of vascular prostheses. In the current era,
we use impregnated vascular grafts (Gelsoft or Gelseal; Vascutek Ltd, Ren-
frewshire, Scotland, UK). For aortic arch replacement a branched prosthe-
sis (Plexus 4, Vascutek Ltd) with separate revascularization of arch vessels
was used, or the arch vessels were implanted using an island technique.6
Patients with descending aortic pathology were operated by lateral tho-
racotomy; patients with thoracoabdominal pathology, by thoracolaparot-
omy with splitting of the diaphragm. In patients with descending aortic
aneurysms, we preferably used a passive shunt until 1983. Thereafter, we
used left heart bypass or full bypass with deep hypothermic circulatory
arrest. For thoracoabdominal aneurysms, we used the clamp-and-sew tech-
nique described by Crawford and colleagues7 until 1988. From 1989 to
1999, a full bypass with deep hypothermic circulatory arrest was used
exclusively. From 1999, we used preferably a left heart bypass. Selective
perfusion of renal arteries and visceral arteries was used in combination
with left heart bypass. Spinal cord fluid drainage was introduced in 2002.
Intercostal, renal, and visceral arteries were implanted in the vascular pros-
thesis used when indicated and feasible.
Follow-up
All patients were monitored at our institution or by their referring car-
diologist. We collected information on vital status, reoperations, and com-
plications. In addition, we consulted the municipal civil registries to
ascertain vital status of all patients. Valve-related complications were
defined according to the 2008 guidelines for reporting morbidity and mor-
tality after cardiac valvular operations.8 Early mortality was defined as
mortality in hospital or within 30 days of surgery.
The study database was frozen for analysis on December 31, 2011.
Follow-up was 99% complete; 11 patients were lost to follow-up. The
mean follow-up duration was 6.0 years (range, 0-35.3 years), with a total
follow-up of 6888 patient-years.
Statistical Methods
Continuous data are presented as mean (standard deviation (SD) and
range). Categorical data are presented as proportions. Differences between
groupswere analyzed using a Student t test or analysis of variancewithBon-
ferroni correction for continuous data and c2 test for categorical data.
Cumulative survivalwas analyzedusing theKaplan-Meiermethod.The sur-
vival of a patient started at the time of operation and ended at the time of
death (event) or at the last follow-up or reoperation (censoring). Compari-
son of Kaplan-Meier estimates was done using the Tarone-Ware test.The Journal of Thoracic and CaUnivariable and multivariable logistic regression analysis (stepwise
backward; inclusion criteria, P  .10; exclusion criteria, P  .10) was
used to study determinants of early mortality. The Cox proportional
hazards model was used for univariable and multivariable analysis of
time-related events. Variables that were tested as potential risk
factors for early and late mortality and reoperations are presented in
Appendix 1. A P value of  .05 was considered statistically significant.
All testing was performed 2 sided. For all analyses, SPSS 17.0 forWindows
statistical software (SPSS, Chicago, Ill) was used.RESULTS
During the study period, 1159 consecutive thoracic aortic
operations were performed in 1075 patients. Sixty-one pa-
tients were operated upon twice; 7 patients, 3 times; and 3
patients, 4 times. Fourteen of 56 patients (25%) with Mar-
fan disease or other connective tissue disease underwent
multiple operations compared with 4 out of 1019 patients
(5.3%) without known genetic diseases (odds ratio [OR],
5.8; 95% confidence interval [CI], 3.0-11.3; P<.001).
Figure 1, A, presents the number of operations per year,
showing a steady increase of the annual number of proce-
dures over time. Figure 1, B, presents the distribution of
the 4 patient groups over time, showing an increase in
ascending aortic aneurysm operations from 23% to 72%
over time. Figure 1, C, presents the distribution of proce-
dures by urgency of operation over time, showing a shift
from 68% acute or urgent operations to 71% elective oper-
ations in the most recent era.
The perioperative data for all operations are shown in
Table 1. In group 1, deep hypothermiawith circulatory arrest
was used in 220 patients (84%; mean duration, 49 minutes;
SD, 35 minutes), and in group 2 in 346 patients (55%; mean
duration, 30minutes; SD, 36minutes). In group 1, antegrade
cerebral perfusion was used in 48 patients (18%; mean du-
ration, 77 minutes; SD, 44minutes), and in group 2 in 62 pa-
tients (10%; mean duration, 83 minutes; SD, 73 minutes).
In 46 patients (26%) in group 3, deep hypothermia with
circulatory arrest was used with a mean duration of 44 min-
utes (SD, 15minutes). In 47 patients (48%) in group 4, deep
hypothermia with circulatory arrest was used with a mean
duration of 51 minutes (SD, 16 minutes).Early Mortality and Morbidity
Early mortality occurred in 167 patients (14.4%); 146
patients (12.6%) died within 30 days postoperatively.
Over time, the early mortality risk decreased from>50%
to 5% in recent years (Figure 1, A). Causes of early mortal-
ity were bleeding (n ¼ 45), cardiac failure (n ¼ 49), sepsis/
multiple-organ failure (n ¼ 30), aortic rupture (n ¼ 13),
neurologic (n ¼ 17), and other causes (n ¼ 13). Mortality
within 60 days was 14.2% (164 patients); mortality within
90 days was 15.6% (180 patients). Figure 2, A, shows the
early mortality per patient group and per 5-year time period.
In all 4 patient groups, the mortality risk decreased signifi-
cantly over time. Early mortality in the most recent timerdiovascular Surgery c Volume 147, Number 1 333
TABLE 1. Indications for thoracic aortic surgery and procedures performed
Group Indication/etiology n Procedure n
Group 1, acute type A dissection (n ¼ 261) Acute type A dissection 261 Ascending aorta
Idiopathic 231 Replacement 252
Marfan/CTD 17 Repair/patch 5
Iatrogenic (CABG/AVR) 9 No ascending aortic procedure* 4
Iatrogenic (PCI) 4
Aortic arch
No arch procedure 37
Hemiarch/open distal anastomosis 187
Replacement 41
Repair/patch 1
Aortic valve
Repair/preservation 177
Mechanical prosthesis 11
Bioprosthesis 3
Allograft 16
Valved conduit 53
T. David/Yacoub 1
Group 2, ascending aorta/aortic arch (n ¼ 626) Chronic type A dissection 46 Ascending aorta
Idiopathic 42 Replacement 591
Marfan/CTD 3 Repair/patch 21
Iatrogenic 1 No ascending aortic procedure 14
Aneurysm 538 Aortic arch
Idiopathic 430 No arch procedure 279
Marfan/CTD 40 Hemiarch/open distal 283
Infectious 10 Replacement 48
Traumatic 1 Replacement with elephant trunk 11
Iatrogenic 4 Repair/patch 5
Allograft failure 4 Aortic valve
Autograft failure 46 No valve procedure 136
False 2 Repair 10
Takayasu arteriitis 1 Mechanical prosthesis 68
Other 42 Bioprosthesis 26
Idiopathic 4 Allograft 67
Marfan/CTD 1 Valved conduit 283
Infectious 5 T. David/Yacoub 32
Traumatic 2 Pulmonary autograft 4
Allograft failure 27
Iatrogenic 2
Aortic arch stenosis 1
Group 3, descending aorta (n ¼ 175) Acute/urgent dissection 26 ECC method
Aneurysm 115 No ECC 49
Idiopathic 75 Passive shunt 53
Marfan/CTD 1 Left heart bypass 27
Postdissection 20 Full bypass with DHCA 46
Infectious 6 Descending aorta
Traumatic 10 Prosthesis 156
False aneurysm 2 With (partial) arch 12
Leiomyosarcoma 1 Patch repair 14
Traumatic aortic rupture 34 With (partial) arch 2
No descending aortic procedure 5y
Reimplantation
Left subclavian artery 13
Intercostal arteries 7
(Continued)
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TABLE 1. Continued
Group Indication/etiology n Procedure n
Group 4, thoracoabdominal aorta (n ¼ 97) Aneurysm 97 ECC method
Idiopathic 71 No ECC 13
Marfan/CTD 7 Left heart bypass 37
Post-dissection 17 Full bypass with DHCA 47
Infectious 1 Thoracoabdominal aorta
Traumatic 1 Prosthesis, distal anastomosis suprarenal 12
Prosthesis, distal anastomosis infrarenal 67
Prosthesis, including bifurcation 17
No aortic procedurez 1
Reimplantation
Left subclavian artery 2
Intercostal arteries 62
Visceral/renal arteries 82
CTD, Connective tissue disease; CABG, coronary artery bypass grafting; AVR, aortic valve replacement; PCI, percutaneous catheter intervention; ECC, extracorporeal circula-
tion; DHCA, deep hypothermia with circulatory arrest. *Two patients were operated by a lateral thoracotomy approach and 2 patients could not be stabilized on extracorporeal
circulation. yFive patients could not be stabilized after thoracotomy. zOne patient could not be stabilized after thoracolaparotomy.
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0% in group 3, and 10.5% in group 4. In group 1, indepen-
dent risk factors for early mortality were earlier year of
operation (OR, 0.961; 95%CI, 0.924-0.999; P¼ .044), col-
lapse as the main presenting symptom (OR, 3.3; 95% CI,
1.3-8.6; P ¼ .013), and preoperative resuscitation (OR,
4.7; 95% CI, 1.0-20.9; P ¼ .044). In group 2, independent
predictors for early mortality were earlier year of operation
(OR, 0.852; 95% CI, 0.812-0.895; P<.001), older patient
age (OR, 1.032; 95% CI, 1.008-1.056; P ¼ .008); higher
Euroscore (OR, 1.047; 95% CI, 1.017-1.077; P ¼ .002),
longer cardiopulmonary bypass time (OR, 1.006; 95% CI,
1.003-1.009; P< .001), and the use of circulatory arrest
(OR, 3.4; 95% CI, 1.1-10.4; P¼ .029). In group 3, indepen-
dent predictors for early mortality included earlier year of
operation (OR, 0.944; 95% CI, 0.898-0.995; P ¼ .026),
older patient age (OR, 1.053; 95% CI, 1.011-1.085;
P ¼ .001), emergency operation (OR, 0.2; 95% CI,
0.1-0.6; P ¼ .001), and postoperative renal dialysis (OR,
8.4; 95% CI, 1.7-41.6; P ¼ .009). Prior aortic surgery
(OR, 0.1; 95% CI, 0.0-0.9; P ¼ .038) was associated with
a reduced early mortality. In group 4, the use of left heart
bypass was associated with reduced early mortality (OR,
0.1; 95%CI, 0.0-0.5; P¼ .005) whereas postoperative renal
dialysis (OR, 8.8; 95% CI, 2.2-35.2; P ¼ .002) was an in-
dependent predictor of early mortality. More details of the
univariable and multivariable analysis of risk factors for
early mortality are presented in Appendix 2.
Table 3 presents postoperative complications by patient
group for 1972 to 2006 compared with the current era. Early
mortality in groups 2, 3, and 4; intensive care unit stay of>2
days in group 2; and ventilatory support more than 1 day in
groups 1, 2, and 3 was less in the current era compared with
1972 to 2006. In groups 1 and 2, the overall stroke rate was
11.9% and 3.2%, respectively, with no difference with
regard to whether circulatory arrest was used (P ¼ .552The Journal of Thoracic and Caand P ¼ .185, respectively).The duration of circulatory
arrest or the use of antegrade cerebral perfusion did not in-
fluence the postoperative stroke rate. The overall paraplegia
rates in groups 3 and 4 were 6.2% and 19.6%, respectively,
and were 0% and 6%, respectively, for patients operated
since 2008.
Late Survival
During follow-up, an additional 330 patients died.
Causes of late death were cardiac in 67 patients, aortic or
vascular related in 33 patients, malignancy in 32 patients,
neurologic in 7 patients, and other or unknown causes in
191 patients.
Overall cumulative survival (including early mortality)
was 54.3% (95% CI, 50.7-57.9) after 10 years and
27.8% (95% CI, 22.6-32.9) after 20 years (Figure 2, B).
Figure 2, C, depicts late survival by decade, showing an ev-
ident improvement of late survival over time except during
the first 2 decades. For the 996 hospital survivors, late sur-
vival was 63.2% (95% CI, 59.3-67.1) after 10 years and
32.3 (95% CI, 26.4-38.3) after 20 years. This was clearly
impaired compared with the age-matched Dutch population
(Figure 2, D). Figure 2, E, depicts the late survival of hospi-
tal survivors per group. Survival of patients with ascending
aortic/aortic arch aneurysms operated after 2000 was
75.8% at 10 years, which is still reduced in comparison
to the 88.0% of an age-matched Dutch male in the general
population (Figure 2, F).
In group 1, independent risk factors for late mortality
were earlier year of operation (Hazard Ratio [HR], 0.960;
95% CI, 0.922-0.998; P ¼ .041), older patient age (HR,
1.046; 95% CI, 1.023-1.069; P < .001), preoperative
obstructive pulmonary disease (HR, 4.2; 95% CI, 1.9-9.3;
P < .001), higher preoperative creatinine levels (HR,
1.003; 95% CI, 1.002-1.005; P<.001), aortic arch replace-
ment (HR, 2.9; 95%CI, 1.2-6.9; P¼ .015), and reduced leftrdiovascular Surgery c Volume 147, Number 1 335
TABLE 2. Preoperative patient characteristics
Characteristic Total (n ¼ 1159)
Group 1,
acute type A
(n ¼ 261)
Group 2,
asc an/chron
type A diss
(n ¼ 626)
Group 3,
descending
(n ¼ 175)
Group 4,
thor-abd
(n ¼ 97) P
Mean age, years, n (SD,
range)
56 (16, 9-83) 58 (13, 19-83) 53 (17, 9-83) 57 (16, 15-79) 64 (9, 34-75) <.001
Male-to-female ratio,
n (%/%)
794/365 (68/32) 166/95 (64/36) 435/191 (70/30) 134/41 (77/23) 59/38 (61/39) .011
Creatinine, mmol/L;
n (SD, range), n ¼ 1109
97 (54, 25-861) 115 (84, 25-861) 88 (31, 27-367) 103 (58, 41-613) 98 (45, 39-385) <.001
Prior cardiac surgery/PCI,
n (%)
226 (19.5) 32 (12.3) 170 (27.2) 10 (5.7) 14 (14.4) <.001
Prior aortic surgery, n (%) 193 (16.7) 13 (5.0) 116 (18.7) 32 (18.3) 32 (33.0) <.001
Hypertension, n (%) 504 (43.5) 138 (52.9) 216 (34.5) 83 (47.4) 67 (69.1) <.001
COPD, n (%) 100 (8.6) 18 (6.9) 46 (7.3) 19 (10.9) 17 (17.5) .004
Prior CVA, n (%) 39 (3.4) 4 (1.5) 27 (4.3) 3 (1.7) 5 (5.2) .077
Diabetes mellitus, n (%) 31 (2.7) 4 (1.5) 18 (2.9) 5 (2.9) 4 (4.1) .631
Prior myocardial infarction,
n (%)
60 (5.2) 14 (5.4) 34 (5.4) 6 (3.4) 6 (6.2) .707
Systolic LVF, n (%), n ¼ 631
Good 476 (75.4) 100 (88.5) 326 (71.2) 18 (85.7) 32 (82.1) .009
Impaired 96 (15.2) 6 (5.3) 85 (18.6) — 5 (12.8)
Moderate/Bad 59 (9.4) 7 (6.2) 47 (10.2) 3 (14.3) 2 (5.1)
Logistic Euroscore, mean
(SD, range)
14.6 (11.2, 5-88) 21.1 (14.4, 5-79) 12.6 (9.5, 5-88) 12.3 (8.6, 5-62) 13.8 (8.2, 5-40) <.001
THAA extent, n (%)
1 6 (6.2)
2 — — — 58 (59.8)
3 32 (33)
4 1 (1.0)
Urgency of operation, n (%)
Acute,<24 h 336 (29.0) 243 (93.1) 27 (4.3) 61 (34.9) 5 (5.2) <.001
Urgent,<14 d 183 (15.8) 18 (6.9) 99 (15.8) 44 (25.1) 22 (22.7)
Elective 640 (55.2) — 500 (79.9) 70 (40.0) 70 (72.2)
asc an/chron type A diss, ascending aortic aneurysm/chronic dissection; thor-abd, thoraco-abdominal aneurysm; SD, standard deviation; PCI, percutaneous catheter intervention;
COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; LVF, left ventricular function; THAA, thoracoabdominal aneurysm.
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In group 2, independent predictors for late mortality were
earlier year of operation (OR, 0.937; 95% CI, 0.913-
0.962; P< .001), older patient age (HR, 1.051; 95% CI,
1.036-1.066; P < .001), higher preoperative creatinine
levels (OR, 1.005; 95% CI, 1.000-1.010; P ¼ .031), higher
Euroscore (OR, 1.024; 95% CI, 1.004-1.045; P ¼ .021),
aortic arch replacement (HR, 1.9; 95% CI, 1.1-3.5;
P ¼ .026), and postoperative myocardial infarction (HR,
5.6; 95% CI, 2.3-13.2; P<.001). In group 3, independent
predictors for late mortality included older patient age
(HR, 1.060; 95% CI, 1.041-1.080; P<.001) and preopera-
tive obstructive pulmonary disease (HR, 1.9; 95% CI, 1.0-
3.5; P ¼ .041); in group 4, older patient age (OR, 1.097;
95% CI, 1.041-1.135; P ¼ .001) was an independent pre-
dictor of late mortality. More details of the univariable
and multivariable analysis of risk factors for late mortality
are presented in Appendix 3.336 The Journal of Thoracic and Cardiovascular SurgReoperations
Eighty patients underwent 111 reoperations. Appendix 4
presents an overview of these reoperations per patient
group. In group 1 (acute type A dissection), most reopera-
tions were for aortic valve incompetence in repaired or pre-
served native aortic valves at the primary operation (n¼ 14)
or structural valve deterioration after allograft implantation
(n ¼ 5). The rate of aortic valve reoperation was increased
in patients with preoperative severe aortic valve insuffi-
ciency who had their aortic valves preserved (HR, 2.9;
95% CI, 1.1-8.2; P ¼ .049). Reoperations for distal aortic
pathology, related to the chronic rest–dissection after re-
paired type A dissection, were more frequent in patients
with a connective tissue disease or with type 1 dissection
versus type 2 dissection, although not significant. The free-
dom from proximal reoperation was 84.6% at 10 years and
71.4% at 15 years. The freedom from distal aortic reopera-
tions was 90.2% after 10 years and 83.7% after 15 years. Inery c January 2014
FIGURE 1. A-C, Overview of number of operations and early mortality
per year (A) distribution over 4 patients groups per 5-year time period
(B) and distribution over 3 urgency classes per 5-year time period (C).
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frequent. In group 2 (chronic aortic aneurysm/dissection),
reoperations were more frequent in patients with Marfan
disease or other known connective tissue diseases with an
HR for proximal reoperation of 3.5 (95% CI, 1.5-8.5;
P ¼ .005) and an HR for distal reoperation of 6.2 (95%
CI, 2.7-14.5; P< .001). Furthermore, distal reoperations
were more frequent after elephant trunk aortic arch
replacement. In group 3 (descending aorta), most reopera-
tions were for abdominal aortic pathology.DISCUSSION
In this article, we provide an overview of all thoracic aor-
tic operations performed in our center between 1972 andThe Journal of Thoracic and Ca2011. The annual number of operations increased during
this 40-year time period to about 10% of the annual case-
load in our department. We demonstrate a shift from 70%
emergency or urgent operations to 70% elective surgeries,
and a shift from predominantly descending aortic opera-
tions to 70% ascending aortic or aortic arch operations,
confirming observations made by Achneck and associates.9
Olsson and colleagues10 also demonstrated an increase in
prevalence of thoracic aortic disease and number of opera-
tions performed between 1987 and 2002 in Sweden. The
increased knowledge of inherited conditions has led to fur-
ther recommendations for early intervention at only slightly
abnormal aortic diameters in patients with specific gene
mutations11,12 and might play an additional role in the
increase of the number of operations performed.
We observed a decrease in descending aortic surgery.
Thoracic endovascular aortic replacement (TEVAR) is in-
creasingly used as the first-choice therapy for descending
aortic aneurysms5 and traumatic aortic rupture with equal
or even lower early mortality and complications.13,14
However, long-term results of TEVAR therapy are still
unknown, and randomized trials comparing open surgery
and TEVAR are lacking, making definitive conclusions on
the merits of TEVAR impossible.15
Over time, early mortality decreased significantly from
>50% early in the series in all 4 patients groups to 15%
for acute type A dissections, 1.9% for other ascending aor-
tic and arch pathology, 0% for descending aortic aneu-
rysms, and 10.5% for thoracoabdominal aneurysms in
the most recent era of 2007 to 2011. These recent early
mortality rates are in line with other published series and
outline the safety of thoracic aortic surgery in the current
era. For acute type A dissections, the International Registry
of Acute Aortic Dissections reports an overall in-hospital
mortality of 23.9% for patients operated on between
1996 and 2003.16 Achneck and colleagues9,17 report
a mortality of 3.0% in elective ascending aorta or arch
surgery, a mortality of 2.9% for elective descending
aortic surgery, and a mortality of 11.9% for elective
thoracoabdominal aortic surgery. Estrera and colleagues18
report a 30-day mortality of 7.3% and an incidence of
2.3% neurologic deficit in 300 patients operated for de-
scending aortic aneurysms.
In a previous study on acute type A dissection, excluding
patients with traumatic or iatrogenic dissections, we found
the reduction in 30-day mortality to be related to technical
improvement in the conduct of the operation.19 The use of
circulatory arrest combined with an open distal anastomosis
and the use of biologic glue were associated with a lower
early mortality.
In descending aortic surgery, the reduction in operative
mortality might be associated with major changes in
operative indications. Acute surgery for traumatic aortic
rupture or complicated dissection is currently replaced byrdiovascular Surgery c Volume 147, Number 1 337
FIGURE 2. Early mortality per patient group and per 5 year time period. A, Overall survival of 1159 patients after thoracic aortic surgery between 1972 and
2011 with 95% confidence interval (B) overall survival after thoracic aortic surgery per decade (C) survival of 996 hospital survivors after thoracic aortic
surgery with 95% confidence interval compared with the survival of a 58-year-old Dutch male (D) survival of hospital survivors per group (E) survival of
417 patients operated for ascending aortic or aortic arch aneurysms between 2000 and 2011 with 95% confidence interval compared with a 54-year-old
Dutch male (F).
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Dendovascular procedures. On the other hand, open surgery
is currently indicated for patients with a chronic dissection
or unfavorable anatomy not amenable to TEVAR proce-
dures. In our patient group with predominantly chronic dis-
sections, or contraindications for TEVAR, we found no
mortality or paraplegia during the last 10 years. Prior aortic
surgery was associated with a lower early mortality; emer-
gency operations were associated with a higher early
mortality.
In the thoracoabdominal aneurysm group with 93% ex-
tent 2 or 3 patients, we found the improvement in early mor-
tality to be related to changes in operative technique. The
currently preferred technique—using left heart bypass, vis-
ceral perfusion, and cerebrospinal fluid drainage—resulted338 The Journal of Thoracic and Cardiovascular Surgin a significantly lower mortality as described by others.20
In this group of patients, we observed a decrease in the para-
plegia rate to 6% since 2008, in line with other contempo-
rary series reported.21
Information on late survival after thoracic aortic surgery
is rare. Kouchoukos and colleagues22 found 10-year sur-
vival rates of 40% to 65% after acute ascending aortic dis-
section, 57% to 75% after other ascending aortic or arch
operations, and 32% to 37% after thoracoabdominal aortic
operations. Olsson and colleagues10 found an overall sur-
vival of hospital survivors of 57% at 10 years and 43% at
15 years in 2455 patients operated for various types of tho-
racic aortic disease between 1987 and 2002. In our series,
we demonstrate an overall long-term survival of 54% atery c January 2014
TABLE 3. Postoperative complications
Complication
Era 1972 to 2006 (n ¼ 801) Era 2007 to 2011 (n ¼ 358)
Group 1
(n ¼ 189)
Group 2
(n ¼ 367)
Group 3
(n ¼ 167)
Group 4
(n ¼ 78)
Group 1
(n ¼ 72)
Group 2
(n ¼ 259)
Group 3
(n ¼ 8)
Group 4
(n ¼ 19)
Early mortality 40 (21.2%) 31 (8.4%) 47 (26.6%) 31 (39.7%) 11 (15.3%) 5 (1.9%)* 0* 2 (10.5%)*
Intensive care unit stay
Mean, days (SD) 8.2 (10.4) 3.4 (5.7) 5.8 (9.5) 15.0 (28.2) 8.2 (12.0) 2.3 (5.6) 3.1 (3.9) 12.7 (12.7)
>2 d 136 (72.0%) 114 (31.1%) 79 (46.1%) 61 (78.2%) 54 (75.0%) 33 (12.7%)* 2 (25.0%) 18 (94.7%)
Ventilation
Mean, days, (SD) 6.2 (9.3) 2.1 (4.8) 4.4 (8.6) 12.2 (31.2) 6.1 (11.9) 1.8 (5.2) 2.0 (2.8) 9.3 (12.2)
>1 d 153 (81.0%) 136 (37.1%) 121 (74.9%) 64 (82.1%) 42 (58.3%)* 21 (8.1%)* 1 (12.5%)* 16 (84.2%)
Tracheostomy 13 (6.9%) 7 (1.9%) 19 (11.4%) 13 (16.7%) 5 (6.9%) 2 (0.8%) 0 1 (5.3%)
Myocardial infarction 12 (6.3%) 10 (2.7%) 2 (1.2%) 4 (5.1%) 1 (1.4%) 4 (1.5%) 0 0
Renal dysfunction
(creatinine>150 mmol/L)
56 (29.6%) 34 (9.3%) 48 (28.7%) 43 (55.1%) 25 (34.7%) 22 (8.5%) 2 (25.0%) 9 (47.4%)
Dialysis 20 (10.6%) 8 (2.2%) 12 (7.2%) 11 (14.1%) 9 (12.5%) 5 (1.9%) 0 5 (26.3%)
Atrial fibrillation 56 (29.6%) 114 (31.1%) 12 (7.2%) 14 (17.9%) 20 (27.8%) 71 (27.4%) 0 2 (10.5%)
Cerebrovascular accident 25 (13.2%) 15 (4.1%) 12 (7.2%) 6 (7.7%) 6 (8.3%) 5 (1.9%) 2 (25.0%) 0
Paraplegia 6 (2.2%) 0 11 (6.3%) 16 (20.5%) 1 (1.4%) 0 0 3 (15.8%)
Recurrent nerve paralysis 8 (3.1%) 10 (1.6%) 24 (13.7%) 10 (10.3%) 0 5 (1.9%) 3 (37.5%) 3 (15.8%)
Delirium 46 (17.6%) 28 (4.5%) 7 (4.0%) 18 (18.6%) 21 (29.2%) 17 (6.6%) 0 3 (15.8%)
SD, Standard deviation. *P<.05 comparing era 2007 to 2011 with era 1972 to 2006.
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survivors was 63% at 10 years and 32% at 15 years, and im-
proved over time. This late survival was reduced when com-
pared with survival in the normal population. Late survival
was reduced after thoracoabdominal aortic surgery related
predominantly to general risk factors for reduced survival.
We found the survival of contemporary patients, operated
since 2000, with ascending aortic or aortic arch aneurysms
to be 76% at 10 years, compared with 88% survival at 10
years with the age-matched general population. This reduc-
tion in 10-year survival has to be weighed against the risk of
a fatal outcome in untreated aortic aneurysms. Davies and
colleagues23 estimate the yearly rate of rupture, dissection,
or death to be 6% for aneurysms 5.0 to 5.9 cm and 15% for
aneurysms>6 cm.23 They found the 5-year survival of non-
operated patients to be 54%, which is clearly inferior than
the survival of operated patients. This information can be
used in advising patients with asymptomatic aneurysms
and may be used to lower the threshold for elective aortic
replacement.
Aortic disease may be present in multiple segments of the
aorta, especially in patients withMarfan disease or other ge-
netic aortic diseases. In our series, 69 of 1075 patients
(6.4%) underwent multiple operations. In patients with ge-
netic diseases, multiple operations were 5-fold more fre-
quent. Multiple operations in patients after acute type A
dissection are reported in 10% to 15% of patients, with
a freedom from reoperation of 71% to 79% after 10
years.24,25 We recently found an increased rate of aortic
valve reoperations in patients presenting with severe
aortic insufficiency preoperatively who had their valves
preserved or after allograft implantation.19 In the currentThe Journal of Thoracic and Caseries, we found 48 reoperations on the aortic valve or the
proximal aorta, with a freedom from proximal reoperation
of 85% at 10 years and 72% at 15 years. Freedom of distal
reoperation after acute type A aortic dissection was 90% at
10 years and 84% at 15 years. Reoperations after descend-
ing aortic replacement were most frequently for abdominal
aortic aneurysms. Reoperations after ascending aortic sur-
gery, other than for acute dissections or thoracoabdominal
aortic surgery, were less frequent.
Study Limitations
Our study presents a retrospective single-center experi-
ence of a 40-year time period. Operations have been per-
formed by 17 different surgeons. During this period,
changes in patient population, operative indications, diag-
nostics, operative and anesthesiologic management, and
conduct of cardiopulmonary bypass have occurred that
can only be evaluated in part. Although follow-up informa-
tion on the vital status of patients is nearly complete, exact
information on the causes of death is not available.
CONCLUSIONS
Thoracic aortic surgery increased in numbers of opera-
tions performed during a 40-year period at our institution.
There has been a shift from predominantly emergency or
urgent operations to elective procedures, and from descend-
ing aortic to ascending aortic operations. Early mortality
decreased significantly over time for all patients groups.
Long-term survival improved significantly over time,
although was still being reduced compared with the general
population. A significant proportion of patients required
multiple operations, especially patients withMarfan diseaserdiovascular Surgery c Volume 147, Number 1 339
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Dor other connective tissue diseases, and patients operated
for acute ascending aortic dissection.
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RISK FACTORS FOR EARLY MORTALITYAFTER
THORACIC AORTIC SURGERY
The following variables were tested as potential risk fac-
tors for early mortality after thoracic aortic surgery: patient
age (continuous variable expressed in years), gender, prior
cardiac surgery, prior aortic surgery, prior myocardial in-
farction, hypertension, chronic obstructive pulmonary dis-
ease using medication or forced expiratory volume in 1
second<70% than predicted, diabetes mellitus (insulin de-
pendent or noninsulin dependent), prior cerebrovascular ac-
cident, dissection type (DeBakey type 1 or 2), etiology
(idiopathic or connective tissue disease), main presenting
symptom (acute pain, collapse/stroke, dyspnea, other), pre-
operative cardiac ischemia, malperfusion (cardiac ischemia,
acute neurologic deficit, vascular dysfunction, paraplegia or
peripheral neurologic deficit), preoperative ventilation sup-
port, preoperative shock (systolic blood pressure<90mm
Hg), preoperative tamponade, preoperative resuscitation,
preoperative pericardial drainage, preoperative renal func-
tion (serum creatinine, continuous variable expressed in mi-
cromoles per liter), systolic left ventricular function (good
vs impaired/moderate/bad), urgency of the procedure
(within 24 hours, within 14 days after onset of complaints,
or elective), logistic Euroscore, year of operation, use of car-
diopulmonary bypass (none, passive shunt, left heart bypass,
full bypass), cardiopulmonary bypass time (continuous vari-
able expressed in minutes), aortic crossclamp time (contin-
uous variable expressed in minutes), use of circulatory
arrest, circulatory arrest time (continuous variable expressed
in minutes), postoperative myocardial infarction, postoper-
ative cerebrovascular accident, postoperative renal dysfunc-
tion (serum creatinine>150 mmol/L), postoperative renal
dialysis, and postoperative paraplegia.ery c January 2014
APPENDIX 2. Univariable and multivariable analysis of factors for early mortality
Factor
Group 1 Group 2 Group 3 Group 4
Univariable
OR (95% CI);
P value
Multivariable
OR (95% CI);
P value
Univariable
OR (95% CI);
P value
Multivariable
OR (95% CI);
P value
Univariable
OR (95% CI);
P value
Multivariable
OR (95% CI);
P value
Univariable
OR (95% CI);
P value
Multivariable
OR (95% CI);
P value
Year of operation 0.962 (0.932-0.993); .018 0.961 (0.924-0.999);
.044
0.887 (0.856-0.919);
<.001
0.852 (0.812-0.895);
<.001
0.928 (0.888-0.969);
.001
0.944 (0.898-0.993);
.026
0.932 (0.882-0.986);
.014
Age 1.032 (1.008-1.056);
.008
1.039 (1.004-1.075);
.029
1.033 (1.008-1.059);
.011
1.053 (1.022-1.085);
.001
Prior CVA 3.0 (1.0-9.4); .049
Prior myocardial infarction 4.3 (0.7-24.7); .104
Collapse main presenting
symptom
4.1 (1.8-9.3); .001 3.3 (1.3-8.6); .013
Prior aortic surgery 0.1 (0.0-0.6); .010 0.1 (0.0-0.9); .038
Preoperative shock 10.6 (2.4-46.4); .002
Preoperative malperfusion 2.6 (1.3-5.2); .005
Preoperative ventilatory
support
6.2 (2.2-17.6); .001
Preoperative resuscitation 6.9 (1.9-25.6); .004 4.7 (1.0-20.9); .044
Preoperative pericardial
drainage
5.6 (1.4-21.8); .012
Preoperative creatinine 1.014 (1.006-1.021);
<.001
Euroscore 1.020 (1.001-1.040); .043 1.024 (0.999-1.050);
.060
1.057 (1.032-1.083);
<.001
1.047 (1.017-1.077);
.002
1.043 (1.004-1.083);
.032
Urgency 1 vs 2-3 0.1 (0.0-0.2);<.001 0.3 (0.2-0.6);
.001
0.2 (0.1-0.6); .001
Use of CPB
None Reference Reference Reference
Passive shunt 2.0 (0.9-4.5); .114 — —
Left heart bypass 0.8 (0.3-2.4); .678 0.121 (0.0-0.5); 004 0.103 (0.0-0.5);
.005
Full bypass/DHCA 0.4 (0.1-1.2); .107 0.424 (0.1-1.5); .182 0.567 (0.1-2.2);
.413
CPB time 1.005 (1.003-1.008);<.001 1.006 (1.004-1.009);
<.001
1.006 (1.003-1.009);
<.001
1.006 (1.001-1.011);
<.012
1.006 (1.001-1.011);
<.012
AoX time 1.006 (1.002-1.011);<.001 1.006 (1.002-1.010);
.004
Use of circulatory arrest 0.5 (0.2-1.1); .091 1.9 (0.9-3.9); .083 3.4 (1.1-10.4);
.029
Glue use 0.5 (0.3-1.0); .039
Postoperative
myocardial infarction
7.3 (2.2-24.4); .001
Postoperative
CVA
3.1 (1.4-6.9); .006 8.2 (3.0-22.9);<.001
Postoperative
dialysis
3.5 (1.5-7.9); .003 8.1 (2.4-27.6); .001 6.4 (1.8-22.3);
.004
8.4 (1.7-41.6); .009 5.9 (1.8-18.9); .003 8.8 (2.2-35.2);
.002
OR, Odds ratio; CI, confidence interval; CVA, cerebrovascular accident; CPB, cardiopulmonary bypass; DHCA, deep hypothermia with circulatory arrest; AoX, aortic crossclamp time.
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APPENDIX 3. Univariable and multivariable analysis of factors for late mortality
Factor
Group 1 Group 2 Group 3 Group 4
Univariable HR
(95% CI); P value
Multivariable HR
(95% CI); P value
Univariable HR
(95% CI); P value
Multivariable HR
(95% CI); P value
Univariable HR
(95% CI); P value
Multivariable HR
(95% CI); P value
Univariable HR
(95% CI); P value
Multivariable HR
(95% CI); P value
Year of operation 0.977 (0.947-1.008);
.142
0.960 (0.922-0.998);
.041
0.957 (0.935-0.980);
<.001
0.937 (0.913-0.962);
<.001
Age 1.039 (1.019-1.060);
<.001
1.046 (1.023-1.069);
<.001
1.051 (1.036-1066);
<.001
1.048 (1.032-1.065);
<.001
1.060 (1.041-1.080);
<.001
1.060 (1.041-1.080);
<.001
1.097 (1.041-1.155);
.001
1.097 (1.041-1.155);
.001
Gender (female vs male) 1.6 (1.1-2.2); .019
TAR vs other 0.2 (0.1-0.5);<.001
Dissection
type (1 vs 2)
1.5 (0.9-2.3); .094
Acute CVA 2.7 (1.1-6.8); .031
Prior myocardial
infarction
2.1 (1.1-4.0); .024 2.5 (1.5-4.3); .001
Hypertension 1.6 (1.0-2.5); .030 1.8 (1.2-2.5); .002 2.2 (1.4-3.4); .001
Diabetes mellitus 4.3 (2.1-8.9);<.001
COPD 3.6 (1.7-7.7); .001 4.2 (1.9-9.3);<.001 3.1 (1.9-5.2);<.001 2.6 (1.4-4.7); .002 1.9 (1.0-3.5); .041
Preoperative creatinine 1.003 (1.002-1.005);
<.001
1.003 (1.002-1.005);
<.001
1.008 (1.003-1.012);
.001
1.005 (1.000-1.010);
.031
Reduced LVF 3.9 (1.4-10.8); .011 6.2 (1.9-20.2); .002
Preoperative severe AI 0.6 (0.3-1.0); .045
Euroscore 1.016 (1.000-1.032);
.046
1.043 (1.025-1.060);
<.001
1.024 (1.004-1.045);
.021
1.055 (1.028-1.083);
<.001
Coronary artery
disease
2.2 (1.4-3.3); .001
Urgency 1 vs 2-3 2.2 (1.1-4.3); .026 2.2 (1.3-3.7); .003
Use of circulatory
arrest
1.7 (1.2-2.5); .005
Aortic arch replacement
None Reference
Hemiarch 1.5 (1.0-2.2); .059
Full arch 2.9 (1.2-6.9);
.015
3.0 (1.8-5.2);<.001 1.9 (1.1-3.5); .026
Postoperative myocardial
infarction
7.9 (3.5-18.2);<.001 5.6 (2.3-13.2);
<.001
Postoperative CVA 2.3 (1.1-5.2); .003
Postoperative renal
dysfunction
2.5 (1.4-3.9); .001 2.2 (1.3-3.7); .003 2.1 (1.3-3.3); .002
HR, Hazard ratio; CI, confidence interval; TAR, traumatic aortic rupture; CVA, cerebrovascular accident; COPD, chronic obstructive pulmonary disease; LVF, left ventricular function; AI, aortic insufficiency.
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APPENDIX 4. Reoperations
Reoperations (%) Type of reoperation n
Group 1 (n ¼ 261) 48
Aortic valve 19 (7.3) Replacement 8
Valved conduit 10
Allograft 1
Ascending aorta/arch 11 (4.2) Valved conduit 2
Ascending/arch replacement 9
Descending/THAA/Abdominal 18 (6.9) Aortic replacement 17
TEVAR 1
Group 2 (n ¼ 626) 43
Aortic valve 9 (1.4) AVR 9
Ascending aorta/arch 9 (1.4) Closure false aneurysm 5
Root replacement (mechanical/allograft)  arch replacement 2
Arch replacement 2
Descending/THAA/abdominal 25 (4.0) Aortic replacement 23
TEVAR 2
Group 3 (n ¼ 175) 18
Ascending aorta/arch 7 (4.0) Acute type 1 dissection 1
Valved conduit 1
Ascending/arch replacement 5
THAA/abdominal 10 (5.7) Abdominal aortic replacement 8
THAA 2
Other 1 (0.6) CABG 1
Group 4 (n ¼ 97) 2
Ascending aorta/arch 1 (1.0) Ascending/arch replacement 1
Descending 1 (1.0) TEVAR 1
THAA, Thoracoabdominal aneurysm; TEVAR, thoracic endovascular aortic replacement; AVR, aortic valve replacement; CABG, coronary artery bypass grafting.
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